Beneski Benjamin Machinas Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$10,838.80

Insider Activity of Beneski Benjamin Machinas

According to the SEC Form 4 filings, Beneski Benjamin Machinas, being in a position of

  1. SVP, Chief Technical Officer at Allogene Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23169 shares for $51,672,
    over all time since 2025-03-14, has bought 0 shares, and sold 28657 shares for $62,511.

Biography of Beneski Benjamin Machinas

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $51,6725100

Comparison of Insiders on Amount of Buys and Sells

2026-03-31SaleAllogene Therapeutics, Inc.
ALLO
SVP, Chief Technical Officer
2,867
0.0012%
$2.50$7,168-18.85%
2026-03-16SaleAllogene Therapeutics, Inc.
ALLO
SVP, Chief Technical Officer
4,835
0.0022%
$2.47$11,942-18.03%
2026-03-02SaleAllogene Therapeutics, Inc.
ALLO
SVP, Chief Technical Officer
7,132
0.003%
$2.60$18,543-23.77%
2026-02-02SaleAllogene Therapeutics, Inc.
ALLO
SVP, Chief Technical Officer
7,549
0.0031%
$1.73$13,060+8.29%
2025-11-17SaleAllogene Therapeutics, Inc.
ALLO
SVP, Chief Technical Officer
786
0.0003%
$1.22$959+54.47%
2025-03-14SaleAllogene Therapeutics, Inc.
ALLO
SVP, Chief Technical Officer
5,488
0.0027%
$1.98$10,839-30.67%
Total: 6
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.